Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 12

1.

Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.

Li L, Turatti F, Crow D, Bading JR, Anderson AL, Poku E, Yazaki PJ, Williams LE, Tamvakis D, Sanders P, Leong D, Raubitschek A, Hudson PJ, Colcher D, Shively JE.

J Nucl Med. 2010 Jul;51(7):1139-46. doi: 10.2967/jnumed.109.074153. Epub 2010 Jun 16.

2.

Antibody vectors for imaging.

Olafsen T, Wu AM.

Semin Nucl Med. 2010 May;40(3):167-81. doi: 10.1053/j.semnuclmed.2009.12.005. Review.

3.

Antibodies for molecular imaging of cancer.

Wu AM, Olafsen T.

Cancer J. 2008 May-Jun;14(3):191-7. doi: 10.1097/PPO.0b013e31817b07ae. Review.

PMID:
18536559
4.

A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.

Li L, Bading J, Yazaki PJ, Ahuja AH, Crow D, Colcher D, Williams LE, Wong JY, Raubitschek A, Shively JE.

Bioconjug Chem. 2008 Jan;19(1):89-96. Epub 2007 Nov 8.

5.

Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.

Li L, Yazaki PJ, Anderson AL, Crow D, Colcher D, Wu AM, Williams LE, Wong JY, Raubitschek A, Shively JE.

Bioconjug Chem. 2006 Jan-Feb;17(1):68-76.

PMID:
16417253
6.

Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.

Olafsen T, Cheung CW, Yazaki PJ, Li L, Sundaresan G, Gambhir SS, Sherman MA, Williams LE, Shively JE, Raubitschek AA, Wu AM.

Protein Eng Des Sel. 2004 Jan;17(1):21-7.

7.

Current use and future potential of organometallic radiopharmaceuticals.

Schibli R, Schubiger PA.

Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1529-42. Epub 2002 Aug 6. Review.

PMID:
12397472
8.
9.

Analysis of renal handling of radiopharmaceuticals.

Trejtnar F, Laznicek M.

Q J Nucl Med. 2002 Sep;46(3):181-94. Review.

PMID:
12134135
10.

Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting.

Kortt AA, Dolezal O, Power BE, Hudson PJ.

Biomol Eng. 2001 Oct 15;18(3):95-108. Review.

PMID:
11566601
11.

Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.

Pavlinkova G, Beresford GW, Booth BJ, Batra SK, Colcher D.

J Nucl Med. 1999 Sep;40(9):1536-46.

12.

Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification.

Delgado C, Pedley RB, Herraez A, Boden R, Boden JA, Keep PA, Chester KA, Fisher D, Begent RH, Francis GE.

Br J Cancer. 1996 Jan;73(2):175-82.

Supplemental Content

Support Center